Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ning Cao

Showing results (351-360 of 362) with videos related to

Pageof 37
Sort By:
Journal of Medicinal Chemistry|May 29, 2007
Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitorsGang Liu, John K Lynch, Jennifer Freeman, et al.
Hepatology (Baltimore, Md.)|May 9, 2015
MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4Jun-Nian Zhou, Quan Zeng, Hai-Yang Wang, et al.
Blood Advances|February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adultsYan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.
Kidney & Blood Pressure Research|November 15, 2017
Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized PatientsSasa Nie, Zhe Feng, Li Tang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A quantitative proteomics dataset for assessment and prediction of low dose X-ray radiation exposure in miceAlex Zelter, Michael Riffle, Gennifer E Merrihew, et al.
Scientific Reports|April 12, 2019
An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis InitiationYing Liu, Degang Wang, Xiangmei Chen, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
BMJ Open|September 11, 2019
Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trialJilin Chen, Ying Liu, Xiangmei Chen, et al.
Blood Purification|August 11, 2022
Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Middle-Molecular-Weight Toxins and Uremic PruritusDelong Zhao, Yuanda Wang, Yong Wang, et al.
American Journal of Nephrology|March 12, 2026
The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (recombinant human erythropoietin), Open-Label Study:the ENARODIAL studyHaishan Wu, Zhen Ai, Aiying Liu, et al.
Pageof 37

Showing results (351-360 of 362) with videos related to

Sort By:
Pageof 37
Journal of Medicinal Chemistry|May 29, 2007
Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitorsGang Liu, John K Lynch, Jennifer Freeman, et al.
Hepatology (Baltimore, Md.)|May 9, 2015
MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4Jun-Nian Zhou, Quan Zeng, Hai-Yang Wang, et al.
Blood Advances|February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adultsYan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.
Kidney & Blood Pressure Research|November 15, 2017
Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized PatientsSasa Nie, Zhe Feng, Li Tang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A quantitative proteomics dataset for assessment and prediction of low dose X-ray radiation exposure in miceAlex Zelter, Michael Riffle, Gennifer E Merrihew, et al.
Scientific Reports|April 12, 2019
An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis InitiationYing Liu, Degang Wang, Xiangmei Chen, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
BMJ Open|September 11, 2019
Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trialJilin Chen, Ying Liu, Xiangmei Chen, et al.
Blood Purification|August 11, 2022
Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Middle-Molecular-Weight Toxins and Uremic PruritusDelong Zhao, Yuanda Wang, Yong Wang, et al.
American Journal of Nephrology|March 12, 2026
The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (recombinant human erythropoietin), Open-Label Study:the ENARODIAL studyHaishan Wu, Zhen Ai, Aiying Liu, et al.
Pageof 37